Cargando…

Utility of the optical quality analysis system for decision-making in Nd: YAG laser posterior capsulotomy in patients with light posterior capsule opacity

BACKGROUND: A prospective cohort study was performed to evaluate whether the Optical Quality Analysis System (OQAS) can serve as a valuable additional indicator for appropriate posterior capsulotomy referral. METHODS: One hundred and five eyes from 96 patients undergoing capsulotomy were divided int...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Bo, Zhu, Weijie, Fan, Yu, Shi, Dong, Ma, Liwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788843/
https://www.ncbi.nlm.nih.gov/pubmed/33407218
http://dx.doi.org/10.1186/s12886-020-01710-8
_version_ 1783633111900225536
author Lu, Bo
Zhu, Weijie
Fan, Yu
Shi, Dong
Ma, Liwei
author_facet Lu, Bo
Zhu, Weijie
Fan, Yu
Shi, Dong
Ma, Liwei
author_sort Lu, Bo
collection PubMed
description BACKGROUND: A prospective cohort study was performed to evaluate whether the Optical Quality Analysis System (OQAS) can serve as a valuable additional indicator for appropriate posterior capsulotomy referral. METHODS: One hundred and five eyes from 96 patients undergoing capsulotomy were divided into precapsulotomy logMAR CDVA ≤0.1 group and logMAR CDVA > 0.1 group. CDVA, and the Visual Function 14 index (VF-14) score were estimated before and 1 month after capsulotomy. The objective scattering index (OSI) value was measured by using the OQAS. Posterior capsule opacification (PCO) severity was assessed with Evaluation of PCO 2000 (EPCO 2000) software. RESULTS: In logMAR CDVA > 0.1 group, the correlations of OSI, logMAR CDVA, EPCO score and VF-14 score were very strong preoperatively. In logMAR CDVA ≤0.1 group, preoperatively, OSI was correlated with logMAR CDVA (r = 0.451), EPCO score (r = 0.789), and VF-14 score (r = 0.852). LogMAR CDVA has weak correlation with VF-14 score (r = − 0.384) and EPCO score (r = 0.566). VF-14 score was correlated with EPCO score (r = − 0.669). In the logMAR CDVA ≤0.1 group, there was no significant difference in logMAR CDVA between precapsulotomy and postcapsulotomy (P > 0.05). In the two groups, all the other optical quality parameters were significantly improved after capsulotomy (P < 0.05). In logMAR CDVA > 0.1 group, the area under the curve of the ROC of the OSI was 0.996 (P = 0.000). In logMAR CDVA ≤0.1 group, the area under the curve of the ROC of the OSI was 0.943 (P = 0.000). CONCLUSIONS: The OSI was useful for evaluating of PCO and prediction of beneficial capsulotomy. Especially for patients with slight PCO and better visual acuity, OSI is more valuable than CDVA and completely objective examination. TRIAL REGISTRATION: The study protocol was registered at the Chinese Clinical Trial Registry. Register: ChiCTR1800018842 (Registered Date: October 13th, 2018).
format Online
Article
Text
id pubmed-7788843
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77888432021-01-07 Utility of the optical quality analysis system for decision-making in Nd: YAG laser posterior capsulotomy in patients with light posterior capsule opacity Lu, Bo Zhu, Weijie Fan, Yu Shi, Dong Ma, Liwei BMC Ophthalmol Research Article BACKGROUND: A prospective cohort study was performed to evaluate whether the Optical Quality Analysis System (OQAS) can serve as a valuable additional indicator for appropriate posterior capsulotomy referral. METHODS: One hundred and five eyes from 96 patients undergoing capsulotomy were divided into precapsulotomy logMAR CDVA ≤0.1 group and logMAR CDVA > 0.1 group. CDVA, and the Visual Function 14 index (VF-14) score were estimated before and 1 month after capsulotomy. The objective scattering index (OSI) value was measured by using the OQAS. Posterior capsule opacification (PCO) severity was assessed with Evaluation of PCO 2000 (EPCO 2000) software. RESULTS: In logMAR CDVA > 0.1 group, the correlations of OSI, logMAR CDVA, EPCO score and VF-14 score were very strong preoperatively. In logMAR CDVA ≤0.1 group, preoperatively, OSI was correlated with logMAR CDVA (r = 0.451), EPCO score (r = 0.789), and VF-14 score (r = 0.852). LogMAR CDVA has weak correlation with VF-14 score (r = − 0.384) and EPCO score (r = 0.566). VF-14 score was correlated with EPCO score (r = − 0.669). In the logMAR CDVA ≤0.1 group, there was no significant difference in logMAR CDVA between precapsulotomy and postcapsulotomy (P > 0.05). In the two groups, all the other optical quality parameters were significantly improved after capsulotomy (P < 0.05). In logMAR CDVA > 0.1 group, the area under the curve of the ROC of the OSI was 0.996 (P = 0.000). In logMAR CDVA ≤0.1 group, the area under the curve of the ROC of the OSI was 0.943 (P = 0.000). CONCLUSIONS: The OSI was useful for evaluating of PCO and prediction of beneficial capsulotomy. Especially for patients with slight PCO and better visual acuity, OSI is more valuable than CDVA and completely objective examination. TRIAL REGISTRATION: The study protocol was registered at the Chinese Clinical Trial Registry. Register: ChiCTR1800018842 (Registered Date: October 13th, 2018). BioMed Central 2021-01-06 /pmc/articles/PMC7788843/ /pubmed/33407218 http://dx.doi.org/10.1186/s12886-020-01710-8 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Lu, Bo
Zhu, Weijie
Fan, Yu
Shi, Dong
Ma, Liwei
Utility of the optical quality analysis system for decision-making in Nd: YAG laser posterior capsulotomy in patients with light posterior capsule opacity
title Utility of the optical quality analysis system for decision-making in Nd: YAG laser posterior capsulotomy in patients with light posterior capsule opacity
title_full Utility of the optical quality analysis system for decision-making in Nd: YAG laser posterior capsulotomy in patients with light posterior capsule opacity
title_fullStr Utility of the optical quality analysis system for decision-making in Nd: YAG laser posterior capsulotomy in patients with light posterior capsule opacity
title_full_unstemmed Utility of the optical quality analysis system for decision-making in Nd: YAG laser posterior capsulotomy in patients with light posterior capsule opacity
title_short Utility of the optical quality analysis system for decision-making in Nd: YAG laser posterior capsulotomy in patients with light posterior capsule opacity
title_sort utility of the optical quality analysis system for decision-making in nd: yag laser posterior capsulotomy in patients with light posterior capsule opacity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788843/
https://www.ncbi.nlm.nih.gov/pubmed/33407218
http://dx.doi.org/10.1186/s12886-020-01710-8
work_keys_str_mv AT lubo utilityoftheopticalqualityanalysissystemfordecisionmakinginndyaglaserposteriorcapsulotomyinpatientswithlightposteriorcapsuleopacity
AT zhuweijie utilityoftheopticalqualityanalysissystemfordecisionmakinginndyaglaserposteriorcapsulotomyinpatientswithlightposteriorcapsuleopacity
AT fanyu utilityoftheopticalqualityanalysissystemfordecisionmakinginndyaglaserposteriorcapsulotomyinpatientswithlightposteriorcapsuleopacity
AT shidong utilityoftheopticalqualityanalysissystemfordecisionmakinginndyaglaserposteriorcapsulotomyinpatientswithlightposteriorcapsuleopacity
AT maliwei utilityoftheopticalqualityanalysissystemfordecisionmakinginndyaglaserposteriorcapsulotomyinpatientswithlightposteriorcapsuleopacity